A Randomized Trial of Switching Antiviral Therapy From Lamivudine to Telbivudine (LdT) vs. Continued Lamivudine Treatment in Adults With Chronic Hepatitis B
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Telbivudine (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Idenix Pharmaceuticals
- 01 May 2011 Results published in Liver International.
- 15 Apr 2007 Status changed from in progress to completed.
- 04 Jan 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History